# Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)

Source: https://onco.cc/trials/nct06427447/  
OnCo record `nct06427447` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in pancreatic cancer, run by Changhai Hospital, now recruiting.

## Summary

Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC) is a phase 3, randomised interventional study registered as NCT06427447 by Changhai Hospital, with a registry enrolment figure of 770 participants, started 2024-08-06 and due to reach its primary completion in 2028-06-30. Interventions recorded: Adjuvant chemoradiotherapy; Adjuvant chemotherapy. Conditions listed: Pancreatic Cancer. Primary outcome: Disease progression free survival will be determined.. Pancreatic eligibility wording from the registry: "* Pathologically confirmed pancreatic ductal adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: ADJUPANC
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06427447
- Phase: 3
- Setting: Adjuvant Chemoradiotherapy Versus Chemotherapy for Post-operative Pancreatic Cancer
- Sponsor: Changhai Hospital
- Enrolled: 770

## Sources

- ClinicalTrials.gov NCT06427447: https://clinicaltrials.gov/study/NCT06427447

## Connected records

- cancers: [Resectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/resectable-pdac/)
- technologies: [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06427447.json